Gilead Sciences (BSP:GILD34) Other Operating Expense : R$0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Gilead Sciences Other Operating Expense?

Gilead Sciences's Other Operating Expense for the three months ended in Mar. 2025 was R$-0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was R$0 Mil.

Gilead Sciences's quarterly Other Operating Expense declined from Sep. 2024 (R$0 Mil) to Dec. 2024 (R$-0 Mil) but then increased from Dec. 2024 (R$-0 Mil) to Mar. 2025 (R$-0 Mil).

Gilead Sciences's annual Other Operating Expense stayed the same from Dec. 2022 (R$0 Mil) to Dec. 2023 (R$0 Mil) but then increased from Dec. 2023 (R$0 Mil) to Dec. 2024 (R$0 Mil).

Gilead Sciences Other Operating Expense Historical Data

The historical data trend for Gilead Sciences's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences Other Operating Expense Chart

Gilead Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

Gilead Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Gilead Sciences Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

Gilead Sciences Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Gilead Sciences's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Gilead Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (BSP:GILD34) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

GILD:USA GILD:Mexico 1GILD:Italy GISd:UK 0QYQ:UK GIS:Germany GIS:Germany GIS:Germany GIS:Germany GILD:Canada GILD:Austria GILD:Argentina

Address

333 Lakeside Drive, Foster City, CA, USA, 94404

Website

https://www.gilead.com

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Gilead Sciences Headlines

No Headlines